Here are the actual results of the clinical studies performed on Prostalex Plus in the Winter of 2005. For more information and the complete text of the clinical study on this product, please send a self-addressed stamped envelope to:
The product used for this Human Clinical Trial was Prostalex Plus at the dosage of 2-capsules taken orally each day.
Fifty subjects with various beginning wellness levels, males over 40 years of age (25 males over 50 years of age), exercise level, and health levels are first tested with clean bodies. Clean bodies meaning they have consumed no prescription drugs, no supplements, and no special diets for 1 week prior to this first intake.
The study was overseen by a Registered Nurse, Medical Doctor, Masters in Holistic Nutrition and Certified Nutritionists.
A Digital Rectal Exam (DRE) for the initial baseline screening was performed by Dr. Elizabeth Masters, M.D. and indicated that on a scale of 1-10 - where 1 is no inflammation and 10 is a state of very enlarged prostate hyperplasia - these 50 subjects where rated between 7-10’s. The following is a list of the subjects’ baseline prostate enlargement scale:
Upon the fourth week of testing, the following levels were measured within these same subjects:
This decrease in prostate inflammation at the end of the fourth week using Prostalex Plus indicated a lowered rate of 24% overall.